A detailed history of Royal Bank Of Canada transactions in Cryo Cell International Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 121 shares of CCEL stock, worth $747. This represents 0.0% of its overall portfolio holdings.

Number of Shares
121
Previous 74 63.51%
Holding current value
$747
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.7 - $9.38 $314 - $440
47 Added 63.51%
121 $0
Q1 2024

May 15, 2024

SELL
$4.86 - $8.04 $140 - $233
-29 Reduced 28.16%
74 $0
Q4 2023

Feb 14, 2024

BUY
$4.19 - $6.6 $427 - $673
102 Added 10200.0%
103 $0
Q3 2023

Nov 14, 2023

SELL
$5.03 - $7.04 $256 - $359
-51 Reduced 98.08%
1 $0
Q2 2023

Aug 14, 2023

BUY
$3.16 - $6.34 $164 - $329
52 New
52 $0
Q3 2022

Nov 14, 2022

SELL
$5.2 - $7.53 $11,091 - $16,061
-2,133 Reduced 96.95%
67 $0
Q2 2022

Aug 15, 2022

BUY
$5.83 - $7.71 $12,826 - $16,962
2,200 New
2,200 $13,000

Others Institutions Holding CCEL

About CRYO CELL INTERNATIONAL INC


  • Ticker CCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 8,519,250
  • Market Cap $52.6M
  • Description
  • Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...
More about CCEL
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.